Beyond infectious disease, GBP2 demonstrates a context-dependent dual role in cancer—acting as either a tumor suppressor or an oncogene by modulating key signaling pathways including JAK-STAT, Wnt/β-catenin, and PI3K/AKT/mTOR. This evidence concerns the gene SOAT1 and infectious disease.